To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Improved exercise hemodyn… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment.

Journal article
Authors Bert Andersson
C Hamm
S Persson
G Wikström
G Sinagra
Åke Hjalmarson
Finn Waagstein
Published in Journal of the American College of Cardiology
Volume 23
Issue 6
Pages 1397-404
ISSN 0735-1097
Publication year 1994
Published at Wallenberg Laboratory
Cardiovascular Institute
Pages 1397-404
Language en
Links www.ncbi.nlm.nih.gov/entrez/query.f...
Keywords Analysis of Variance, Cardiomyopathy, Dilated, drug therapy, epidemiology, physiopathology, Double-Blind Method, Europe, Exercise, physiology, Female, Hemodynamics, drug effects, Humans, Male, Metoprolol, therapeutic use, Middle Aged, North America, Time Factors
Subject categories Cardiac and Cardiovascular Systems

Abstract

This study was performed to investigate exercise hemodynamic status in a double-blind, placebo-controlled trial and was a substudy in the Metoprolol in Dilated Cardiomyopathy Trial.Previous open studies have shown beneficial effects on exercise hemodynamic status after beta-adrenergic blocking agent therapy in patients with congestive heart failure.The study included 41 patients with idiopathic dilated cardiomyopathy with ejection fraction < 0.40 (metoprolol, 20 patients; placebo, 21 patients) whose hemodynamic status was investigated at rest and during supine submaximal exercise, at baseline and after 6 and 12 months of treatment. Myocardial metabolism was evaluated in a subset of 19 patients.Metoprolol-treated patients responded favorably, as expressed by improved exercise cardiac index ([mean +/- SD] placebo 4.8 +/- 1.6 to 4.7 +/- 1.8 liters/min per m2, metoprolol 4.3 +/- 1.1 to 5.4 +/- 1.9 liters/min per m2, p = 0.0001) and stroke work index (placebo 44 +/- 20 to 41 +/- 27 g.m/m2, metoprolol 35 +/- 16 to 58 +/- 28 g.m/m2, p < 0.0001). Exercise systolic arterial pressure increased (placebo 161 +/- 25 to 151 +/- 23 mm Hg, metoprolol 155 +/- 29 to 165 +/- 37 mm Hg, p = 0.0003) as well as exercise oxygen consumption index (placebo 463 +/- 194 to 474 +/- 232 ml/min per m2, metoprolol 406 +/- 272 to 507 +/- 298 ml/min per m2, p = 0.045). There was a significant increase in exercise duration in the metoprolol group (63 +/- 38 s) compared with the placebo group (-24 +/- 42 s) (p = 0.01). Net myocardial lactate extraction increased in the metoprolol group, suggesting less myocardial ischemia (placebo 17 +/- 22 to 9.5 +/- 6.4 mmol/min, metoprolol -32 +/- 100 to 42 +/- 45 mmol/min, p = 0.03). Peripheral levels of norepinephrine tended to decrease at rest and during exercise, whereas myocardial net spillover was unchanged.Metoprolol improved hemodynamic status in patients with dilated cardiomyopathy at rest and had a more pronounced effect during exercise. These positive effects were achieved along with improved or stable myocardial metabolic data.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://gu.se/english/research/publication/?languageId=100001&disableRedirect=true&returnUrl=http%3A%2F%2Fgu.se%2Fforskning%2Fpublikation%2F%3FtipFriend%3Dtrue%26tipUrl%3Dhttp%253A%252F%252Fgu.se%252Fforskning%252Fpublikation%252F%253Fprint%253Dtrue%2526publicationId%253D266121%26print%3Dtrue%26publicationId%3D266121&tipFriend=true&tipUrl=http%3A%2F%2Fgu.se%2Fforskning%2Fpublikation%2F%3Fprint%3Dtrue%26publicationId%3D266121&publicationId=266121
Utskriftsdatum: 2020-07-05